5751 - 5775 of 9131 Results
Title
Year
-
OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 62
-
OPENTitle: Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity ActJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 706181End Page: 706181Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2021.706181Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.706181/pdfCitation Count: 27
-
OPENTitle: Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 177End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202285?id=journal-of-parkinsons-disease%2Fjpd202285Citation Count: 61
-
OPENTitle: The mechanisms of smell loss after SARS-CoV-2 infectionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 693End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00202-7Best OA location URL: http://www.thelancet.com/article/S1474442221002027/pdfCitation Count: 23
-
OPENTitle: New transgenic models of Parkinson's disease using genome editing technologyJournal Name: Neurología (English Edition)Publisher: Elsevier BVVol: 35Issue #: 7Start Page: 486End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nrleng.2017.08.006Best OA location URL: https://doi.org/10.1016/j.nrleng.2017.08.006Citation Count: 3
-
OPENTitle: Early postnatal injections of whole vaccines compared to placebo controls: Differential behavioural outcomes in miceJournal Name: Journal of Inorganic BiochemistryPublisher: Elsevier BVVol: 212Issue #:Start Page: 111200End Page: 111200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jinorgbio.2020.111200Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0162013420302282?via%3DihubCitation Count: 5
-
OPENTitle: The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-SynucleinJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 432Issue #: 24Start Page: 166706End Page: 166706Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2020.11.005Best OA location URL: https://researchportal.bath.ac.uk/en/publications/fb730497-1b80-42eb-b3a3-b52e364bb049Citation Count: 16
- Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence2019RESTRICTEDTitle: Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalenceJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 408Issue #:Start Page: 116523End Page: 116523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.116523Citation Count: 53
- A validation of a self-administered screening test for Parkinson's disease2020RESTRICTEDTitle: A validation of a self-administered screening test for Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 418Issue #:Start Page: 117116End Page: 117116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117116Citation Count: 5
-
OPENTitle: A revolution in biochemistry and molecular biology education informed by basic research to meet the demands of 21st century career pathsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 295Issue #: 31Start Page: 10653End Page: 10661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.aw120.011104Best OA location URL: https://doi.org/10.1074/jbc.aw120.011104Citation Count: 27
- Low cerebrospinal fluid volume and the risk for post-lumbar puncture headaches2020RESTRICTEDTitle: Low cerebrospinal fluid volume and the risk for post-lumbar puncture headachesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 417Issue #:Start Page: 117059End Page: 117059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117059Citation Count: 8
-
OPENTitle: The age-related trajectory of visual attention neural function is altered in adults living with HIV: A cross-sectional MEG studyJournal Name: EBioMedicinePublisher: Elsevier BVVol: 61Issue #:Start Page: 103065End Page: 103065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.103065Best OA location URL: http://www.thelancet.com/article/S2352396420304412/pdfCitation Count: 31
- Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studies2020RESTRICTEDTitle: Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studiesJournal Name: European Journal of Medicinal ChemistryPublisher: Elsevier BVVol: 207Issue #:Start Page: 112705End Page: 112705Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmech.2020.112705Citation Count: 16
- Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation2020RESTRICTEDTitle: Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiationJournal Name: Cancer LettersPublisher: Elsevier BVVol: 493Issue #:Start Page: 31End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.canlet.2020.07.015Citation Count: 24
- Aggressiveness after centromedian nucleus stimulation engages prefrontal thalamocortical circuitry2019OPENTitle: Aggressiveness after centromedian nucleus stimulation engages prefrontal thalamocortical circuitryJournal Name: Brain StimulationPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 357End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.10.023Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X19304346/pdfCitation Count: 18
-
OPENTitle: PDmethDB: A curated Parkinson’s disease associated methylation information databaseJournal Name: Computational and Structural Biotechnology JournalPublisher: American Association for the Advancement of Science (AAAS)Vol: 18Issue #:Start Page: 3745End Page: 3749Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.csbj.2020.11.015Best OA location URL: https://doi.org/10.1016/j.csbj.2020.11.015Citation Count: 13
-
OPENTitle: Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: a prospective studyJournal Name: Journal of Clinical Sleep MedicinePublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.10268Best OA location URL: https://jcsm.aasm.org/doi/pdf/10.5664/jcsm.10268Citation Count: 6
-
OPENTitle: Perception of whole-body motion during balance perturbations is impaired in Parkinson's disease and is associated with balance impairmentJournal Name: Gait & PosturePublisher: Elsevier BVVol: 76Issue #:Start Page: 44End Page: 50Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2019.10.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7015810Citation Count: 14
-
RESTRICTEDTitle: Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's DiseaseJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 82Issue #: 10Start Page: 1027End Page: 1053Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40265-022-01747-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-022-01747-7.pdfCitation Count: 1
-
OPENTitle: Clinical and Demographic Characteristics of Upper Limb DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2086End Page: 2090Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28223Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8350751Citation Count: 13
- Timing Is Everything: The T‐Cell Response to α‐Synuclein Is Maximal in Early Parkinson's2020RESTRICTEDTitle: Timing Is Everything: The T‐Cell Response to α‐Synuclein Is Maximal in Early Parkinson'sJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1137End Page: 1137Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28122Citation Count: 8
- Restless Leg Syndrome and Objectively‐Measured Atherosclerosis in the Canadian Longitudinal Study on Aging2020RESTRICTEDTitle: Restless Leg Syndrome and Objectively‐Measured Atherosclerosis in the Canadian Longitudinal Study on AgingJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2314End Page: 2318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28326Citation Count: 9
- The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease2020RESTRICTEDTitle: The Discovery of LRRK2 Mutations as a Cause of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 551End Page: 554Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27999Citation Count: 5
- Measuring Functional Status in Huntington's Disease2020RESTRICTEDTitle: Measuring Functional Status in Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 757End Page: 761Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28363Citation Count: 8
-
OPENTitle: The Role of Transportation in the Enrollment of Elderly African Americans into Exercise and Memory Study: GEMS StudyJournal Name: Journal of Racial and Ethnic Health DisparitiesPublisher: Springer Science and Business Media LLCVol: 10Issue #: 4Start Page: 1837End Page: 1845Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40615-022-01367-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40615-022-01367-7.pdfCitation Count: 3